Evogene Ltd. Filing Effectiveness Notice
Ticker: EVGN · Form: EFFECT · Filed: Apr 16, 2026 · CIK: 0001574565
Sentiment: neutral
Topics: registration-statement, effectiveness
TL;DR
Evogene EFFECT filing effective 4/16/26. Registration statement is live.
AI Summary
Evogene Ltd. filed an EFFECT form on April 16, 2026, indicating the effectiveness of a registration statement. The filing, with accession number 9999999995-26-001196, relates to Act 33 and File No. 333-294650. The company's business address is 13 Gad Feinstein Street Park, Rehovot, Israel.
Why It Matters
This filing signifies that a registration statement for Evogene Ltd. has become effective, which is a crucial step for certain securities offerings or transactions.
Risk Assessment
Risk Level: low — This is a procedural filing indicating the effectiveness of a registration statement, not a direct financial event.
Key Numbers
- 2026-04-16 — Filing Date (Date the EFFECT filing was accepted by the SEC.)
- 333-294650 — File Number (Associated SEC file number for this registration.)
Key Players & Entities
- Evogene Ltd. (company) — Filer
- 0001574565 (company) — CIK
- 333-294650 (dollar_amount) — File Number
- 2026-04-16 (date) — Filing Acceptance Date
- 2026-04-15 (date) — Effectiveness Date
FAQ
What type of registration statement has become effective for Evogene Ltd.?
The filing indicates the effectiveness of a registration statement under Act 33, File No. 333-294650.
What is the accession number for this filing?
The accession number for this filing is 9999999995-26-001196.
When was this filing accepted by the SEC?
The filing was accepted on April 16, 2026.
What is Evogene Ltd.'s CIK number?
Evogene Ltd.'s CIK number is 0001574565.
Where is Evogene Ltd. located?
Evogene Ltd.'s business address is 13 Gad Feinstein Street Park, Rehovot, Israel.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 16, 2026 regarding Evogene Ltd. (EVGN).